Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate sedation in elderly patients undergoing non-general anesthesia surgery
ChiCTR2100048744Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of remimazolam (2 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoints: Sedation success rate and Incidence of changes in cognitive function within one week after surgery. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2100048744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048744.